770 related articles for article (PubMed ID: 6368032)
1. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests.
Gatehouse D; Wedd DJ
Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032
[TBL] [Abstract][Full Text] [Related]
2. A demonstration of the in vitro bacterial mutagenicity of procarbazine, using the microtitre fluctuation test and large concentrations of S9 fraction.
Gatehouse DG; Paes DJ
Carcinogenesis; 1983; 4(3):347-52. PubMed ID: 6339100
[TBL] [Abstract][Full Text] [Related]
3. Mutagenicity of 2-methylacrolein, 2-ethylacrolein and 2-propylacrolein in Salmonella typhimurium TA100. A comparative study.
Neudecker T; Eder E; Deininger C; Henschler D
Mutat Res; 1991 Dec; 264(4):193-6. PubMed ID: 1723498
[TBL] [Abstract][Full Text] [Related]
4. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment.
Traynor CA; Shane BS; Hajos AK; Winston GW
Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800
[TBL] [Abstract][Full Text] [Related]
5. Genetic effects of isoniazid and the relationship to in vivo and in vitro biotransformation.
Braun R; Jäkel HP; Schöneich J
Mutat Res; 1984; 137(2-3):61-9. PubMed ID: 6381996
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
[TBL] [Abstract][Full Text] [Related]
7. Mutagenic activation of 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole(Trp-P-1) and 3-amino-1-methyl-5H-pyrido(4,3-b)indole (Trp-P-2) by primary cultures of adult rat hepatocytes: effect of Aroclor induction in vitro.
Decloître F; Hamon G; Martin M; Thybaud-Lambay V
Mutat Res; 1984; 137(2-3):123-32. PubMed ID: 6433191
[TBL] [Abstract][Full Text] [Related]
8. Increased mutagenicity of chloroethylnitrosoureas in the presence of a rat liver S9 microsome mixture.
Suling WJ; Rice LS; Shannon WM
J Natl Cancer Inst; 1983 Apr; 70(4):767-9. PubMed ID: 6220173
[TBL] [Abstract][Full Text] [Related]
9. Activation and detoxication of promutagens by toadfish (Opsanus tau) hepatic postmitochondrial fractions in the Salmonella assay.
Milling DM; Maddock MB
Mutat Res; 1986 Apr; 164(2):81-9. PubMed ID: 3515163
[TBL] [Abstract][Full Text] [Related]
10. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
[TBL] [Abstract][Full Text] [Related]
11. The hair-dye reagent 2-(2',4'-diaminophenoxy)ethanol is mutagenic to Salmonella typhimurium.
Venitt S; Crofton-Sleigh C; Osborne MR
Mutat Res; 1984 Jan; 135(1):31-47. PubMed ID: 6363911
[TBL] [Abstract][Full Text] [Related]
12. The mutagenic activity of chlorpromazine.
Obaseiki-Ebor EE; Akerele JO
Mutat Res; 1988 May; 208(1):33-8. PubMed ID: 3285202
[TBL] [Abstract][Full Text] [Related]
13. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
[TBL] [Abstract][Full Text] [Related]
14. Activation of the food mutagens IQ and MeIQ by hepatic S9 fractions derived from various species.
Alldrick AJ; Rowland IR
Mutat Res; 1985 Oct; 144(2):59-62. PubMed ID: 3900706
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide: lack of mutagenic activity across phyla and genetic endpoints.
Ashby J; Tinwell H; Callander RD; Kimber I; Clay P; Galloway SM; Hill RB; Greenwood SK; Gaulden ME; Ferguson MJ; Vogel E; Nivard M; Parry JM; Williamson J
Mutat Res; 1997 Dec; 396(1-2):45-64. PubMed ID: 9434859
[TBL] [Abstract][Full Text] [Related]
16. Mutagenic evaluation of trichlorfon using different assay methods with Salmonella typhimurium.
Barrueco C; Herrera A; de la Peña E
Mutagenesis; 1991 Jan; 6(1):71-6. PubMed ID: 2038275
[TBL] [Abstract][Full Text] [Related]
17. Mutagenicity of potassium alkanediazotates and their use as model compounds for activated nitrosamines.
Hecker LI; Saavedra JE; Farrelly JG; Andrews AW
Cancer Res; 1983 Sep; 43(9):4078-82. PubMed ID: 6347365
[TBL] [Abstract][Full Text] [Related]
18. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
[TBL] [Abstract][Full Text] [Related]
19. The Salmonella/mammalian microsome mutagenicity test: comparison of human and rat livers as activating systems.
Beaune P; Lemestré-Cornet R; Kremers P; Albert A; Gielen J
Mutat Res; 1985 Jun; 156(3):139-46. PubMed ID: 3889631
[TBL] [Abstract][Full Text] [Related]
20. The influence of automobile exhausts on mutagenicity of soils: contamination with, fractionation, separation, and preliminary identification of mutagens in the Salmonella/reversion assay and effects of solvent fractions on the sister-chromatid exchanges in human lymphocyte cultures and in the in vivo mouse bone marrow micronucleus assay.
Wesp HF; Tang X; Edenharder R
Mutat Res; 2000 Dec; 472(1-2):1-21. PubMed ID: 11113694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
